Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

di Catania, Giovanna, Malaguti, Paola, Gasparro, Simona, Cognetti, Francesco, Vidiri, Antonello, Fabi, Alessandra
Pubblicato in Oncology (2018)

Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis

di RUSSILLO, MICHELANGELO, FERRETTI, GIANLUIGI, VIDIRI, ANTONELLO, GASPARRO, SIMONA, COGNETTI, FRANCESCO, PELLEGRINI, DOMENICA, FABI, ALESSANDRA
Pubblicato in In Vivo (2018)

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

di Santini, Daniele, Vincenzi, Bruno, Schiavon, Gaia, La Cesa, Annalisa, Gasparro, Simona, Vincenzi, Angelo, Tonini, Giuseppe
Pubblicazione 2006

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2...

di Rossi, Valentina, Berchialla, Paola, Giannarelli, Diana, Nisticò, Cecilia, Ferretti, Gianluigi, Gasparro, Simona, Russillo, Michelangelo, Catania, Giovanna, Vigna, Leonardo, Mancusi, Rossella Letizia, Bria, Emilio, Montemurro, Filippo, Cognetti, Francesco, Fabi, Alessandra
Pubblicato in Cancers (Basel) (2019)